By vgreene, 15 March, 2021 Therapeutic Potential of Ivermectin as Add On Treatment in COVID 19 A Systematic Review and Meta analysis
By vgreene, 15 March, 2021 Study considerations multihospital retrospective cohort study possible timing bias as more of the control group enrolled in 1st weeks of study pts also received other tx incl HCQ AZ or both
By vgreene, 15 March, 2021 KEY FINDINGS ivermectin tx associated w lower mortality esp in pts w severe pulmonary involvement
By vgreene, 15 March, 2021 Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019
By vgreene, 15 March, 2021 Study considerations double blind RCT small sample size early viral clearance not shown in ivermectin doxycycline group
By vgreene, 15 March, 2021 KEY FINDINGS early viral clearance observed in ivermectin treated pts vs placebo 5 day course of ivermectin may be safe and effective in mild dz
By vgreene, 15 March, 2021 A Five day Course of Ivermectin for the Treatment of COVID 19 May Reduce the Duration of Illness
